New test helps doctors ID kidney disease cause

(HealthDay)—A new test that helps doctors identify the cause of a specific type of kidney disease has been approved by the U.S. Food and Drug Administration.

Membranous glomerulonephritis (MGN) damages blood vessels in the kidneys that help filter the blood. Some cases are caused by the body's rejection of its own (autoimmune), while the rest are triggered by other causes such as infection, the FDA said in a news release.

The Euroimmun Anti- Pla2r IFA test detects an antibody that is present if the cause of MGN is autoimmune, the FDA said.

In a clinical study of 560 blood samples, the test detected autoimmune cases of MGN in 77 percent of samples donated by people presumed to have this form, the agency said.

The test should not be the sole determinant of MGN's cause, nor should a negative test rule out a specific cause, the FDA said.

The test is manufactured by Euroimmun US, based in Morris Plains, N.J.

More information: Visit the FDA to learn more.

add to favorites email to friend print save as pdf

Related Stories

New test IDs genotype of hepatitis C

Jun 20, 2013

(HealthDay)—A new test to help doctors identify the genotype of a person's hepatitis C infection has been approved by the U.S. Food and Drug Administration.

Recommended for you

Seaweed menace may yield new medicines

17 hours ago

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

User comments